Skip to main content
 

Sameer Pal
Click to enlarge

Sameer Pal

 Partner

Sameer has been with Rapid Innovation Group since its inception having previously worked for Mercer Management Consulting in New York.

In his capacity as RIG’s Commercial Director, Sameer’s role is to drive the global cross-industry deal-making that sits at the heart of RIG’s work with our clients. He takes an enabling role in executing major licensing, high value product transactions, and offtake deals. He has a particular skill in commercial negotiation.

As precursory activities to effective deal making that optimises value, Sameer has extensive experience: of orchestrating market / application discovery and validation exercises; in strategy development; and in business model selection.

He also has a particular interest in driving growth for European technology companies in the Asian market.

Sameer has a double major in International Relations and History, with a minor in Economics, from Franklin and Marshall College in Lancaster, Pennsylvania. Sameer has lived in six different countries and speaks Hindi and Bengali fluently and can order from the menu in French.

ClearLeaf Inc. Partners with Summit Agro International to Bring GotaBlanca® to Japan and South Korea

After nearly three years of joint testing with RIG client ClearLeaf on a variety of pathogens in crops of commercial importance, Summit Agro International has acquired exclusive rights for the market development and distribution of ClearLeaf's flagship product, GotaBlanca, in Japan and South Korea

 

BRAIN Biotech AG and Akribion Therapeutics GmbH sign exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology

RIG client Akribion Therapeutics is progressing the development of the CRISPR-Cas9 technology, with initial applications in oncology 

 

SolasCure Publishes Phase IIa Clinical Trial Report in Leading Wound Care Journal

RIG client SolasCure has published further data to support the use of their enzymatic debridement product to accelerate wound healing